Toraih, E.A.; Alenezy, A.; Hussein, M.H.; Hashmat, S.; Mummadi, S.; Alrawili, N.F.; Abdelmaksoud, A.; Fawzy, M.S.
The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort. Biomedicines 2025, 13, 1049.
https://doi.org/10.3390/biomedicines13051049
AMA Style
Toraih EA, Alenezy A, Hussein MH, Hashmat S, Mummadi S, Alrawili NF, Abdelmaksoud A, Fawzy MS.
The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort. Biomedicines. 2025; 13(5):1049.
https://doi.org/10.3390/biomedicines13051049
Chicago/Turabian Style
Toraih, Eman A., Awwad Alenezy, Mohammad H. Hussein, Shahmeer Hashmat, Saitej Mummadi, Nawaf Farhan Alrawili, Ahmed Abdelmaksoud, and Manal S. Fawzy.
2025. "The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort" Biomedicines 13, no. 5: 1049.
https://doi.org/10.3390/biomedicines13051049
APA Style
Toraih, E. A., Alenezy, A., Hussein, M. H., Hashmat, S., Mummadi, S., Alrawili, N. F., Abdelmaksoud, A., & Fawzy, M. S.
(2025). The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort. Biomedicines, 13(5), 1049.
https://doi.org/10.3390/biomedicines13051049
